3646 results for «529»

Filter By

3646 results

Diagnosis and classification of tricuspid regurgitation

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.

Diagnosis and classification of tricuspid regurgitation

Transcatheter tricuspid valve interventions: procedural considerations

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.

Transcatheter tricuspid valve interventions: procedural considerations

Transcatheter tricuspid valve interventions: outcomes

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.

Transcatheter tricuspid valve interventions: outcomes

Multiple VHD: a diagnostic and clinical challenge

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.

Multiple VHD: a diagnostic and clinical challenge

STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

25 Oct 2025

Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.

Elad Asher

Author

Elad Asher
STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART
Didn’t find what you were looking for?